Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on June 12, 2014. The filing serves to announce the financial results for the fiscal quarter and fiscal year ended March 31, 2014. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the content of which is not included in the provided source text.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the period ended March 31, 2014.
Guidance, Outlook, and Risks
The report includes standard forward-looking statements regarding the company's intentions, beliefs, expectations, and strategies. Management notes that these statements are based on current assumptions and are not guarantees of future performance. Actual results may differ materially due to risks, uncertainties, and assumptions discussed in the company's Annual Report on Form 10-K and other SEC filings. The company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, cash position) by reviewing the press release attached as Exhibit 99.1.
- Confirm the company name discrepancy: The request metadata lists "Sonoma Pharmaceuticals, Inc.," but the filing is explicitly for "Oculus Innovative Sciences, Inc."
- Review the company's most recent Form 10-K for detailed risk factors referenced in the forward-looking statements.
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act.